Exome sequencing revealed that the XYAM-2 cell line was negative for mutations in major melanoma driver genes, including BRAF, NRAS, and NF1. Similarly, our WES analysis revealed that the KS-NailMel-1 cells are negative for mutations in these genes (Supplementary Table S3). This evidence concerns the gene BRAF and melanoma.